← Leaderboards
Joan Ripley Coates
University Of Missouri-Columbia
$645,522
Attributed
$881,855
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $276.4K · FY2012–19$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$881,855 · 2
By mechanism
R21$881,855 · 2
Top collaborators
- Sarah A. Moore2 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Martin L Katz$6,047,835
- Sarah A. Moore$718,853
- Martin K. Childers$7,329,077
- Teresa E Lever$2,231,298
Others in their field
Top investigators on “Novel Therapeutics”
- David Heimbrook · Leidos Biomedical Research, Inc.$355,066,875
- Judith S. Currier · University Of California Los Angeles$321,442,024
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
- Sharon A Nachman · Johns Hopkins University$212,395,175
Research focus
Novel TherapeuticsRodentInheritedNeurodegenerative DisordersResearch PersonnelRandomizedDisease ProgressionFutureInnovationNervous System StructureAnimal ModelPre-ClinicalCanis FamiliarisAffectAmyotrophic Lateral SclerosisDisease ModelAdultDog DiseasesBaseClinical TrialsAnimal Disease ModelsMissense MutationComparativeRodent Model
Grant awards (4)
A platform trial design to accelerate translational therapies in a canine disease model of ALS$196,284
R21 · FY2019 · TR · contact PI
A platform trial design to accelerate translational therapies in a canine disease model of ALS$276,382
R21 · FY2018 · TR · contact PI
Therapeutic Development for Amyotrophic Lateral Sclerosis in a Canine Model$223,938
R21 · FY2013 · NS · contact PI
Therapeutic Development for Amyotrophic Lateral Sclerosis in a Canine Model$185,251
R21 · FY2012 · NS · contact PI